• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Inhibition of HIF-la activity is a novel strategy for the treatment of tubulointerstitial fibrosis

Research Project

Project/Area Number 17590839
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionNara Medical University

Principal Investigator

IWANO Masayuki  Nara Medical University, First Department of Internal Medicine, Associate Professor, 医学部, 講師 (20275324)

Co-Investigator(Kenkyū-buntansha) SAITO Yoshihiko  Nara Medical University, First Department of Internal Medicine, Professor, 医学部, 教授 (30250260)
AKAI Yasuhiro  Nara Medical University, First Department of Internal Medicine, Associate Professor, 医学部, 講師 (30326326)
Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 2006: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2005: ¥2,000,000 (Direct Cost: ¥2,000,000)
Keywordshypoxia / interstitial fibrosis / renal failure / fibroblast / tubular epithelial cell / FSP1 / EMT / HIF-1α / YC-1
Research Abstract

Chronic hypoxia is a main contributor to the progression of tubulointerstitial fibrosis. In this study, we investigated the extent to which hypoxia-inducible factor 1α (HIF-1α) mediates epithelial-mesenchymal-transition (EMT) in vivo and in vitro using a mouse model in which renal proximal epithelial HIF-1α expression was selectively deleted and assessed the role of HIF-1α in EMT-mediated renal fibrosis. In addition, we developed a method with which to detect EMT in vitro, using Cre-recombinase activated β-galactosidase (LacZ) to identify and track primary tubular epithelial cells (TECs). To determine whether HIF-la is involved in the development of tubulointerstitial fibrosis in vivo, renal fibrosis was induced by unilateral urethral obstruction (UUO) in HIF-la-mutant and wild-type mice. Kidneys were harvested for immunohistochemistry 8 days after UUO and stained for FSP1 (fibroblast-specific protein 1, a marker for EMT) using a modified ABC-peroxidase method. Numbers of FSP1+ cells w … More ere significantly lower in obstructed kidneys from HIF-1α-mutant than wild type mice. Moreover, after exposure to hypoxia (1% O_2), but not normoxia (20.9% O_2), for 5 days cultured TECs permanently marked with LacZ assumed a fibroblast-like morphology. And double staining for LacZ and FSP1 revealed that whereas 8.2% of TECs underwent EMT (LacZ+/FSP1+) under normoxic conditions, 28.3% underwent EMT under hypoxic conditions. We also determined that blockade of HIF-1α activity can be a novel approach for the treatment of tubulointerstitial fibrosis through the inhibition of epithelial-mesenchymal-transition (EMT) in vitro and in vivo, using YC-1(3-(5'-hydroxymethy1-2'-fury1)-1-benzyl indazole) as an anti-HIF-1α agent.
Taken together, our results suggest that, through activation of HIF-1, hypoxia plays a key role in the induction of EMT and in EMT-mediated renal fibrosis in vitro and in vivo and anti-HIF-1α agents may be utilized for the treatment of tubulointerstitial fibrosis through the inhibition of EMT. Less

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (7 results)

All 2007 2005

All Journal Article (6 results) Book (1 results)

  • [Journal Article] FSP 1 as a marker for renal survival2007

    • Author(s)
      Iwano M
    • Journal Title

      Annual Review 2007 total

      Pages: 308-308

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Fibroblast-specific protein 1 is a specific marker for renal survival in patients with IgAN2005

    • Author(s)
      Nishitani Y
    • Journal Title

      Kidney Int 68・3

      Pages: 1078-1085

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] 間質線維化の発症機序と治療戦略2005

    • Author(s)
      岩野正之
    • Journal Title

      Nephrology Frontier 4・4

      Pages: 65-73

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Fibroblast-specific protein 1 is a specific marker for renal survival in patients with IgAN2005

    • Author(s)
      Nishitani Y
    • Journal Title

      Kidney Int 68(3)

      Pages: 1078-1085

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Strategy for the treatment of interstitial fibrosis2005

    • Author(s)
      Iwano M
    • Journal Title

      Nephrology Frontier 4(4)

      Pages: 65-73

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Fibroblast-specific protein 1 is a specific marker for renal survival in patients with IgAN2005

    • Author(s)
      Nishitani Y, Iwano M, et al.
    • Journal Title

      Kidney International 68(3)

      Pages: 1078-1085

    • Related Report
      2005 Annual Research Report
  • [Book] Annual Review 2007 腎臓2007

    • Author(s)
      岩野正之
    • Total Pages
      308
    • Publisher
      中外医学社
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Annual Research Report 2006 Final Research Report Summary

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi